Clinical Trial Update: Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Ivonescimab in combination with chemoradiotherapy for high-risk locoregionally advanced nasopharyngeal carcinoma; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma (NPC) | Phase 2 | Status: NOT_YET_RECRUITING